RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use

YY Syed - Drugs & Therapy Perspectives, 2022 - Springer
… Economic impact of introducing the RTS, S malaria vaccine: cost-effectiveness and
budget impact analysis in 41 countries. MDM Policy Pract. 2019;4(2):2381468319873324. …

[HTML][HTML] Modelling the cost-effectiveness of introducing the RTS, S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa

P Winskill, PGT Walker, JT Griffin, AC Ghani - BMJ Global Health, 2017 - gh.bmj.com
… the RTS,S malaria vaccine generally only enters the optimal pathway of scale-up of
interventions once very high coverage of vector control interventions, along with seasonal malaria

Mosquirix™ RTS, S/AS01 vaccine development, immunogenicity, and efficacy

AY Nadeem, A Shehzad, SU Islam, EA Al-Suhaimi… - Vaccines, 2022 - mdpi.com
… on the execution of the first malarial vaccine directed by the WHO [… RTS, S vaccine for the
health of the general population. The RTS, S vaccine is the most sophisticated malarial vaccine

The RTS, S malaria vaccine: Current impact and foundation for the future

JG Beeson, L Kurtovic, C Valim, KP Asante… - Science Translational …, 2022 - science.org
… Obtaining an effective malaria vaccine has … a malaria vaccine called RTS,S for widespread
use in young children was an important milestone. RTS,S is a virus-like particle (VLP) vaccine

[HTML][HTML] Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

…, CA Bever, C Sauboin, K Galactionova, S Flasche… - The Lancet, 2016 - thelancet.com
… impact and cost-effectiveness of routine use of the RTS,S/AS01 vaccine in African settings. …
cost-effectiveness in the presence of existing malaria interventions for vaccine prices of US…

RTS, S malaria vaccine and increased mortality in girls

SL Klein, F Shann, WJ Moss, CS Benn, P Aaby - MBio, 2016 - Am Soc Microbiol
malaria causes approximately 10% of all deaths in children under 5 years of age. The
RTS,S/AS01 malaria vaccine … to be 18 to 36% efficacious against clinical malaria (1). Although the …

Insights from modelling malaria vaccines for policy decisions: the focus on RTS, S

K Galactionova, TA Smith, MA Penny - Malaria journal, 2021 - Springer
… on malaria vaccine modelling, with a focus on its link to the development of policy guidance
for the first licensed product, RTS,S/… of action and efficacy profile of RTS,S; to predicting the …

Implementation of RTS, S/AS01 malaria vaccine—the need for further evidence

J Clemens, V Moorthy - New England Journal of Medicine, 2016 - Mass Medical Soc
… against all malaria episodes by the malaria vaccine was 28% … The malaria vaccine efficacy
declined over time and became … -dose group; the vaccine efficacy declined more slowly in the …

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: a review

…, A Nadeem, W Bilal, F Ansar, S Saleem… - Immunity …, 2023 - Wiley Online Library
… After evaluating RTS, S/AS01 for its safety, effectiveness, and … It was suggested that the
RTS, S malaria vaccine be used … The successful pilot program testing the malaria vaccine in …

Economic impact of introducing the RTS, S malaria vaccine: cost-effectiveness and budget impact analysis in 41 countries

C Sauboin, LA Van Bellinghen… - MDM Policy & …, 2019 - journals.sagepub.com
Malaria is a major public health burden in sub-Saharan Africa. This study estimated the
cost-effectiveness and budget impact of adding four-dose malaria vaccination in infants or …